Zentalis Pharmaceuticals furnishes corporate presentation; no specific new data disclosed in excerpt

Zentalis Pharmaceuticals, Inc.

Presentation dated September 2023 will be used in investor meetings and conferences.
No financial results, pipeline updates, or guidance changes are available from the provided exhibit excerpt.
Filing under Regulation FD; information is furnished, not filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.